197 related articles for article (PubMed ID: 33383048)
1. FGF9 induces neurite outgrowth upon ERK signaling in knock-in striatal Huntington's disease cells.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Life Sci; 2021 Feb; 267():118952. PubMed ID: 33383048
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast Growth Factor 9 Stimulates Neuronal Length Through NF-kB Signaling in Striatal Cell Huntington's Disease Models.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Chen CM; Yang SH
Mol Neurobiol; 2021 May; 58(5):2396-2406. PubMed ID: 33421017
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast Growth Factor 9 Suppresses Striatal Cell Death Dominantly Through ERK Signaling in Huntington's Disease.
Yusuf IO; Cheng PH; Chen HM; Chang YF; Chang CY; Yang HI; Lin CW; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
Cell Physiol Biochem; 2018; 48(2):605-617. PubMed ID: 30021209
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease.
Yusuf IO; Chen HM; Cheng PH; Chang CY; Tsai SJ; Chuang JI; Wu CC; Huang BM; Sun HS; Yang SH
Free Radic Biol Med; 2019 Jan; 130():256-266. PubMed ID: 30391672
[TBL] [Abstract][Full Text] [Related]
5. Differential proteomic and genomic profiling of mouse striatal cell model of Huntington's disease and control; probable implications to the disease biology.
Choudhury KR; Das S; Bhattacharyya NP
J Proteomics; 2016 Jan; 132():155-66. PubMed ID: 26581643
[TBL] [Abstract][Full Text] [Related]
6. Striatal neurons expressing full-length mutant huntingtin exhibit decreased N-cadherin and altered neuritogenesis.
Reis SA; Thompson MN; Lee JM; Fossale E; Kim HH; Liao JK; Moskowitz MA; Shaw SY; Dong L; Haggarty SJ; MacDonald ME; Seong IS
Hum Mol Genet; 2011 Jun; 20(12):2344-55. PubMed ID: 21447599
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Bim contributes to the potentiation of serum deprivation-induced apoptotic cell death in Huntington's disease knock-in striatal cell line.
Kong PJ; Kil MO; Lee H; Kim SS; Johnson GV; Chun W
Neurol Res; 2009 Feb; 31(1):77-83. PubMed ID: 18691453
[TBL] [Abstract][Full Text] [Related]
8. Increased 90-kDa ribosomal S6 kinase (Rsk) activity is protective against mutant huntingtin toxicity.
Xifró X; Anglada-Huguet M; Rué L; Saavedra A; Pérez-Navarro E; Alberch J
Mol Neurodegener; 2011 Oct; 6():74. PubMed ID: 22041125
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of system xc(-) expression induced by mutant huntingtin in a striatal neuronal cell line and in R6/2 mice.
Frederick NM; Bertho J; Patel KK; Petr GT; Bakradze E; Smith SB; Rosenberg PA
Neurochem Int; 2014 Oct; 76():59-69. PubMed ID: 25004085
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease.
Silva A; Naia L; Dominguez A; Ribeiro M; Rodrigues J; Vieira OV; Lessmann V; Rego AC
Neurodegener Dis; 2015; 15(4):207-18. PubMed ID: 25896770
[TBL] [Abstract][Full Text] [Related]
12. The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington's disease and in striatal tissue from Huntington's disease patients.
Laprairie RB; Warford JR; Hutchings S; Robertson GS; Kelly ME; Denovan-Wright EM
J Neuroimmunol; 2014 Feb; 267(1-2):61-72. PubMed ID: 24360910
[TBL] [Abstract][Full Text] [Related]
13. FGF9-induced changes in cellular redox status and HO-1 upregulation are FGFR-dependent and proceed through both ERK and AKT to induce CREB and Nrf2 activation.
Chuang JI; Huang JY; Tsai SJ; Sun HS; Yang SH; Chuang PC; Huang BM; Ching CH
Free Radic Biol Med; 2015 Dec; 89():274-86. PubMed ID: 26424114
[TBL] [Abstract][Full Text] [Related]
14. Heterozygous huntingtin promotes cadmium neurotoxicity and neurodegeneration in striatal cells via altered metal transport and protein kinase C delta dependent oxidative stress and apoptosis signaling mechanisms.
Kwakye GF; Jiménez JA; Thomas MG; Kingsley BA; McIIvin M; Saito MA; Korley EM
Neurotoxicology; 2019 Jan; 70():48-61. PubMed ID: 30399392
[TBL] [Abstract][Full Text] [Related]
15. Calcineurin is involved in the early activation of NMDA-mediated cell death in mutant huntingtin knock-in striatal cells.
Xifró X; García-Martínez JM; Del Toro D; Alberch J; Pérez-Navarro E
J Neurochem; 2008 Jun; 105(5):1596-612. PubMed ID: 18221365
[TBL] [Abstract][Full Text] [Related]
16. Intracranial self-stimulation-reward or immobilization-aversion had different effects on neurite extension and the ERK pathway in neurotransmitter-sensitive mutant PC12 cells.
Gomita Y; Esumi S; Ushio S; Kitamura Y; Sendo T; Motoda H; Inoue S; Araki H; Kano Y
Behav Brain Res; 2021 Jan; 396():112920. PubMed ID: 32961216
[TBL] [Abstract][Full Text] [Related]
17. The serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways.
Speranza L; Chambery A; Di Domenico M; Crispino M; Severino V; Volpicelli F; Leopoldo M; Bellenchi GC; di Porzio U; Perrone-Capano C
Neuropharmacology; 2013 Apr; 67():155-67. PubMed ID: 23164613
[TBL] [Abstract][Full Text] [Related]
18. The common inhaled anesthetic isoflurane increases aggregation of huntingtin and alters calcium homeostasis in a cell model of Huntington's disease.
Wang Q; Liang G; Yang H; Wang S; Eckenhoff MF; Wei H
Toxicol Appl Pharmacol; 2011 Feb; 250(3):291-8. PubMed ID: 21059370
[TBL] [Abstract][Full Text] [Related]
19. The death receptor antagonist FAIM promotes neurite outgrowth by a mechanism that depends on ERK and NF-kapp B signaling.
Sole C; Dolcet X; Segura MF; Gutierrez H; Diaz-Meco MT; Gozzelino R; Sanchis D; Bayascas JR; Gallego C; Moscat J; Davies AM; Comella JX
J Cell Biol; 2004 Nov; 167(3):479-92. PubMed ID: 15520226
[TBL] [Abstract][Full Text] [Related]
20. Pizotifen Activates ERK and Provides Neuroprotection in vitro and in vivo in Models of Huntington's Disease.
Sarantos MR; Papanikolaou T; Ellerby LM; Hughes RE
J Huntingtons Dis; 2012; 1(2):195-210. PubMed ID: 23393546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
